Stem Cell Therapy

Stem Cell Therapy encompasses regenerative medicine approaches utilising stem cells' unique properties including self-renewal and differentiation potential to repair, replace, or regenerate damaged tissues, treating diseases through cellular mechanisms impossible with conventional medicines. These strategies employ various stem cell types including haematopoietic stem cells treating blood disorders, mesenchymal stromal cells modulating immunity, pluripotent stem cell derivatives replacing degenerated tissues, or tissue-specific progenitors renewing organ function.

The biopharmaceutical industry has established haematopoietic stem cell transplantation as standard care for leukaemia and genetic blood disorders whilst developing numerous investigational therapies addressing degenerative diseases, injuries, and autoimmune conditions. Allogeneic transplantation uses donor stem cells providing new immune systems or correcting genetic defects, requiring immunosuppression to manage graft-versus-host disease. Autologous approaches employ patient cells avoiding rejection. Manufacturing processes include cell procurement through bone marrow harvest, mobilised blood collection, or differentiation from pluripotent sources, followed by processing, potential genetic modification, expansion, differentiation, formulation, and quality control. Safety considerations include tumourigenicity from pluripotent cells, immunological complications, and ectopic tissue formation. As manufacturing improves, genome editing enables genetic correction, and clinical evidence accumulates, stem cell therapy continues maturing offering transformative regenerative treatments addressing diseases through cellular repair and replacement.